W.W. Grainger, Inc.

No forensic scores are on file for Grainger in this data, so this synthesis does not give a Beneish M-Score, Piotroski F-Score, Altman Z-Score, or Fog Index value, and no score label is interpreted here. That absence is itself a reason for readers to work through the primary filings. The revenue line is the clearest number in the data: $17.94 billion for 2025, up from $17.17 billion in 2024 and $11.22 billion in 2018. Those figures describe a business that has grown in most recent years, but the data does not include margins, operating cash flow, or net income, so this synthesis cannot say whether that growth has translated into profit. The Q1 2026 10-Q excerpt covers Item 3, Item 4, Part II items, and exhibits. It states that market risk exposures remain foreign currency and commodity price risk, with no material change from the 2025 Form 10-K, and that disclosure controls were concluded effective as of March 31, 2026, with no material change in internal control over financial reporting in the quarter. Legal proceedings are incorporated by reference to Note 7, which is not included in this excerpt. Readers may want to open Note 7 and the 2025 Form 10-K risk factors to see which matters are pending. The filing also describes the 2024 Program, under which 217,626 shares were repurchased in the quarter with 2,924,966 remaining. The May 1, 2026 commercial paper program, capped at $1.25 billion outstanding with maturities up to 397 days, is a new financing channel disclosed after quarter end. Readers may want to watch how the company uses it alongside its cash position in future filings.

Catalyst.The MD&A excerpt in this data does not include the quarter's results narrative, so the operating drivers cannot be confirmed from it. The annual revenue series shows growth from $11.22 billion in 2018 to $17.94 billion in 2025, and from $17.17 billion in 2024 to $17.94 billion in 2025, a rise of about 4.5%. In the first quarter of 2026, the company repurchased 217,626 shares under its 2024 Program, which authorized up to five million shares, leaving 2,924,966 shares available under that program. On May 1, 2026, Grainger established a commercial paper program of up to $1.25 billion outstanding at any time.

Hidden risk.The most material tension a casual reader could miss is that the risk-factor text is not in this data. The 10-Q states there were no material changes from the risk factors in the 2025 Form 10-K, so readers may want to read that 10-K section directly. The forward-looking statements list is long and names items such as tariffs, pricing statutes tied to disaster declarations, group purchasing organization contracts, and cybersecurity. The new commercial paper program allows up to $1.25 billion outstanding at any time with maturities up to 397 days, so short-term borrowing capacity is growing at the same time the company is repurchasing shares. Readers may want to compare these two items in future filings.